Mutations in the PSEN1 gene encoding
presenilin 1 (PS1) are linked to a vast majority of pedigrees with early-onset, autosomal dominant forms of familial
Alzheimer's disease (
FAD). Lewy body (LB) pathology is frequently found in the brains of
FAD patients harboring PSEN1 mutations. We recently reported on a novel PS1 mutation with the deletion of
threonine at
codon 440 (deltaT440) in a familial case diagnosed as having the neocortical type of
dementia with LBs (DLB) and variant AD. In this report, we investigated the possible involvement of PS1 deltaT440 mutation in aberrant
alpha-synuclein accumulation. We established cell lines that stably express either wild-type (WT) PS1 or the
FAD-linked PS1 H163R, E280A, deltaE9, and PS1 deltaT440 mutants and now demonstrate that the expression of the PS1 deltaT440 mutant led to a marked elevation in the ratio of
beta-amyloid (Abeta) 42/40
peptides in a
conditioned medium. More importantly, we report here that the levels of phosphorylated
alpha-synuclein increase in neuronal and non-neuronal cells expressing the PS1 deltaT440 mutant compared with cells that express WT PS1 or the PS1 H163R and E280A variants that are not associated with LB pathology. This finding is consistent with our demonstration of elevated levels of phosphorylated
alpha-synuclein in the
detergent-resistant fraction prepared from a patient's brain with PS1 deltaT440 mutation. These observations raise the intriguing suggestion that the mechanism(s) by which the PS1 deltaT440 mutant causes DLB and variant AD are by enhancing the phosphorylation of
alpha-synuclein and the ratio of Abeta(42/40)
peptides, respectively, in the brain.